B Lynne Parshall is Director of CYTOKINETICS INC. Currently has a direct ownership of 20,600 shares of CYTK, which is worth approximately $1.03 Million. The most recent transaction as insider was on May 12, 2021, when has been sold 5,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K
0% 3M change
37.33% 12M change
Total Value Held $1.03 Million

B LYNNE PARSHALL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 50.0%
5,000 Common Stock
Oct 05 2020
SELL
Open market or private sale
$1,509,330 $30.0 p/Share
50,311 Reduced 100.0%
0 Common Stock
Oct 05 2020
BUY
Exercise of conversion of derivative security
$392,426 $7.8 p/Share
50,311 Added 89.45%
5,936 Common Stock

Also insider at

IONS
IONIS PHARMACEUTICALS INC Healthcare
FHTX
Foghorn Therapeutics Inc. Healthcare
BLP

B Lynne Parshall

Director
Carlsbad, CA

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK